Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate the importance of topoisomerases for transcription of the galactose induced genes, we have studied the expression of
GAL1
, GAL2, GAL7 and GAL10 in Saccharomyces cerevisiae cells deficient for topoisomerases I and II. We find that topoisomerases are required for transcriptional activation of the GAL genes, but are dispensable for ongoing transcription, eliminating a role of the enzymes in transcriptional elongation. Furthermore, we demonstrate that promoter chromatin remodeling of the GAL genes is unaffected in the topoisomerase deficient strain. However, the cells fail to successfully recruit RNA polymerase II due to an inability of the
TATA-binding protein
(
TBP
) to bind to the TATA box in these promoters. We therefore argue that topoisomerases are required for accurate assembly of the preinitiation complex at the promoters of the GAL genes.
...
PMID:DNA Topoisomerases Are Required for Preinitiation Complex Assembly during GAL Gene Activation. 2617 27
Transcription factor II D (TFIID), a multiprotein complex consisting of
TATA-binding protein
(
TBP
) and 13-14
TBP
-associated factors (Tafs), plays a central role in transcription and regulates nearly all class II genes. The N-terminal domain of Taf1p (TAND) can be divided into two subdomains, TAND1 and TAND2, which bind to the concave and convex surfaces of
TBP
, respectively. The interaction between TAND and
TBP
is thought to be regulated by TFIIA, activators and/or DNA during transcriptional activation, as the TAND1-bound form of
TBP
cannot bind to the TATA box. We previously demonstrated that Drosophila TAND1 binds to
TBP
with a much stronger affinity than yeast TAND1 and that the expression levels of full-length chimeric Taf1p, whose TAND1 is replaced with the Drosophila counterpart, can be varied in vivo by substituting several methionine residues downstream of TAND2 with alanine residues in various combinations. In this study, we examined the transcriptional activation of the
GAL1
-lacZ reporter or endogenous genes such as RNR3 or
GAL1
in yeast cells expressing various levels of full-length chimeric Taf1p. The results showed that the substitution of TAND1 with the Drosophila counterpart in yeast TFIID weakened the transcriptional activation of
GAL1
-lacZ and RNR3 but not that of
GAL1
. These findings strongly support a model in which
TBP
must be released efficiently from TAND1 within TFIID upon transcriptional activation.
...
PMID:Transcriptional activation is weakened when Taf1p N-terminal domain 1 is substituted with its Drosophila counterpart in yeast TFIID. 3090 91
<< Previous
1
2